PATENT CLAIM ANALYSIS

Application Number: 15777223
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "030000"]

Abstract:
The invention provides novel compounds that are derivatives of Azithromycin and that have been found by the current inventors to have low antimicrobial activity but significant epithelial barrier enhancement properties. The invention further provides use of the compounds as a medicament, in particular in the treatment or prophylaxis of a disease or condition that is caused by a defect in epithelial cells or tissue, or a disease or condition that benefits from enhancement or restoration of epithelial barrier function, for example diseases of the respiratory tract.

Claim (Index 27):
The method of  claim 26  wherein the disease or condition is an airways disease and the epithelial tissue is in the respiratory tract epithelial tissue, particularly a part of the respiratory tract selected from the group consisting of nose, nasal cavity, sinuses, larynx, trachea, bronchi, bronchioles, terminal airways and alveoli.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 93.0
- Lexical Diversity: 1.625
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14902129', '10421577', '10218154', '10840529', '09485292']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.850425224184834
- 35 USC 102 Novelty (BERT): 0.5381280647531624
- Combined Prediction Score: 0.8191955082416669
- Mean Citation Score: 400.387328
- Max Citation Score: 434.61444000000006
- Similarity Product: 207.41194832159405

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test